Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Archrock
AROC
$6.27B
| $659K | ﹤0.01% |
+32,600
| New | +$646K |
|
527
Rocket Pharmaceuticals
RCKT
$340M
| $658K | ﹤0.01% |
30,578
+3,795
| +14% | +$87.2K |
|
528
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
| $655K | ﹤0.01% |
1,223
+557
| +84% | +$300K |
|
529
Adaptive Biotechnologies
ADPT
$3.59B
| $643K | ﹤0.01% |
177,623
+2,856
| +2% | +$9.06K |
|
|
DX
530
Dynex Capital
DX
$3.15B
| $637K | ﹤0.01% |
+53,379
| New | +$641K |
|
531
Atkore
ATKR
$2.46B
| $633K | ﹤0.01% |
4,691
-242
| -5% | -$38.5K |
|
|
PRMW
532
DELISTED
Primo Water Corporation
PRMW
| $606K | ﹤0.01% |
+27,712
| New | +$570K |
|
533
Marathon Digital Holdings
MARA
$4.32B
| $602K | ﹤0.01% |
30,323
+1,809
| +6% | +$34.4K |
|
534
Tanger
SKT
$4.67B
| $602K | ﹤0.01% |
+22,200
| New | +$611K |
|
535
Macerich
MAC
$7.33B
| $601K | ﹤0.01% |
38,921
+3,998
| +11% | +$61.2K |
|
536
Celsius Holdings
CELH
$7.47B
| $599K | ﹤0.01% |
10,493
+3,180
| +43% | +$240K |
|
537
Sprouts Farmers Market
SFM
$8.13B
| $598K | ﹤0.01% |
+7,142
| New | +$520K |
|
538
Magnolia Oil & Gas
MGY
$6.09B
| $591K | ﹤0.01% |
+23,330
| New | +$595K |
|
|
RDFN
539
DELISTED
Redfin
RDFN
| $589K | ﹤0.01% |
98,073
+3,874
| +4% | +$24.2K |
|
540
Editas Medicine
EDIT
$396M
| $583K | ﹤0.01% |
124,888
+18,368
| +17% | +$104K |
|
541
Monolithic Power Systems
MPWR
$70.1B
| $581K | ﹤0.01% |
707
| – | – |
|
|
WIRE
542
DELISTED
Encore Wire Corp
WIRE
| $575K | ﹤0.01% |
1,984
-1,021
| -34% | -$288K |
|
543
FirstService
FSV
$6.48B
| $574K | ﹤0.01% |
3,773
-1,510
| -29% | -$228K |
|
|
CHX
544
DELISTED
ChampionX
CHX
| $572K | ﹤0.01% |
+17,234
| New | +$588K |
|
545
Sphere Entertainment
SPHR
$5.14B
| $567K | ﹤0.01% |
16,178
+402
| +3% | +$15.6K |
|
546
Fluor
FLR
$7.01B
| $553K | ﹤0.01% |
+12,699
| New | +$528K |
|
|
REVG
547
DELISTED
REV Group
REVG
| $548K | ﹤0.01% |
+22,029
| New | +$541K |
|
548
CONMED
CNMD
$1.39B
| $541K | ﹤0.01% |
7,806
-341,630
| -98% | -$24.9M |
|
549
Upwork
UPWK
$1.13B
| $499K | ﹤0.01% |
+46,408
| New | +$527K |
|
550
Hubbell
HUBB
$25B
| $479K | ﹤0.01% |
1,310
+279
| +27% | +$109K |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.